Evidence map›Paper›PMID 39143266›Full record

ArticleNature metabolism2024

S-acylation of ATGL is required for lipid droplet homoeostasis in hepatocytes.

Yuping Zheng, Jishun Chen, Vinitha Macwan, Charneal L Dixon, Xinran Li, Shengjie Liu, Yuyun Yu, Pinglong Xu, Qiming Sun, Qi Hu and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Lipid Droplet Dynamics in Alcoholic Steatohepatitis.The American journal of pathology · 2026
    Review
  11. Article
  12. Review
  13. Review
  14. Activation of Focal Adhesion Pathway byAnimals : an open access journal from MDPI · 2025
    Article
  15. Review
  16. Article
  17. Review
  18. Palmitoylation in cardiovascular diseases: Molecular mechanism and therapeutic potential.International journal of cardiology. Heart & vasculature · 2025
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yuping Zheng *Center for Metabolism Research, The Fourth Affiliated Hospital of School of Medicine and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.ORCID http://orcid.org/0000-0001-5527-0604
Jishun Chen *Department of Cell Biology, Zhejiang University School of Medicine, Hangzhou, China.ORCID http://orcid.org/0000-0002-4639-7395
Vinitha Macwan *Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Charneal L Dixon *Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University Health Network, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0003-4283-732X
Xinran LiZJU-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou, China.ORCID http://orcid.org/0000-0003-2805-3510
Shengjie LiuWestlake AI Therapeutics Lab, Westlake Laboratory of Life Sciences and Biomedicine, School of Life Sciences, Westlake University, Hangzhou, China.ORCID http://orcid.org/0000-0002-2018-1609
Yuyun YuCenter for Metabolism Research, The Fourth Affiliated Hospital of School of Medicine and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.
Pinglong XuLife Science Institute, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0001-7726-5443
Qiming SunCenter for Metabolism Research, The Fourth Affiliated Hospital of School of Medicine and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.
Qi HuWestlake AI Therapeutics Lab, Westlake Laboratory of Life Sciences and Biomedicine, School of Life Sciences, Westlake University, Hangzhou, China.ORCID http://orcid.org/0000-0001-7803-7821
Wei LiuCenter for Metabolism Research, The Fourth Affiliated Hospital of School of Medicine and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China. liuwei666@zju.edu.cn.ORCID http://orcid.org/0000-0002-8033-4718
Brian RaughtPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. brian.raught@uhnresearch.ca.ORCID http://orcid.org/0000-0001-6145-4776
Gregory D FairnKeenan Research Centre for Biomedical Science, St. Michael's Hospital, University Health Network, Toronto, Ontario, Canada. gfairn@dal.ca.ORCID http://orcid.org/0000-0001-6508-168X
Dante NeculaiCenter for Metabolism Research, The Fourth Affiliated Hospital of School of Medicine and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China. dneculai@zju.edu.cn.ORCID http://orcid.org/0000-0001-8887-9168

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipid droplets (LDs) are organelles specialized in the storage of neutral lipids, cholesterol esters and triglycerides, thereby protecting cells from the toxicity of excess lipids while allowing for the mobilization of lipids in times of nutrient deprivation. Defects in LD function are associated with many diseases. S-acylation mediated by zDHHC acyltransferases modifies thousands of proteins, yet the physiological impact of this post-translational modification on individual proteins is poorly understood. Here, we show that zDHHC11 regulates LD catabolism by modifying adipose triacylglyceride lipase (ATGL), the rate-limiting enzyme of lipolysis, both in hepatocyte cultures and in mice. zDHHC11 S-acylates ATGL at cysteine 15. Preventing the S-acylation of ATGL renders it catalytically inactive despite proper localization. Overexpression of zDHHC11 reduces LD size, whereas its elimination enlarges LDs. Mutating ATGL cysteine 15 phenocopies zDHHC11 loss, causing LD accumulation, defective lipolysis and lipophagy. Our results reveal S-acylation as a mode of regulation of ATGL function and LD homoeostasis. Modulating this pathway may offer therapeutic potential for treating diseases linked to defective lipolysis, such as fatty liver disease.

Indexed as

AcyltransferasesHepatocytesHomeostasisLipaseLipid DropletsLipolysisAcylationAnimalsHumansLipid MetabolismMiceAcyltransferasesLipasePNPLA2 protein, mouse

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.